<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/P6153>	<http://www.wikidata.org/entity/statement/Q63393796-FCF7CD14-CA70-4397-9A08-1427BD655AC1> .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/direct/P17>	<http://www.wikidata.org/entity/Q38> .
<http://www.wikidata.org/entity/Q63393796>	<http://www.w3.org/2004/02/skos/core#prefLabel>	"Avelumab and Talazoparib in Untreated Advanced Ovarian Cancer (JAVELIN OVARIAN PARP 100)"@en .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/direct/P17>	<http://www.wikidata.org/entity/Q191> .
<http://www.wikidata.org/entity/Q63393796>	<http://schema.org/description>	"ensayu cl\u00EDnicu"@ast .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/P3098>	<http://www.wikidata.org/entity/statement/Q63393796-10374E97-A46B-4FD9-A147-E369FF6F6FFC> .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/P859>	<http://www.wikidata.org/entity/statement/Q63393796-664F64CD-838E-4A76-B088-0E1881BACDF4> .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/P4844>	<http://www.wikidata.org/entity/statement/Q63393796-83C117ED-E85B-49B4-8F8C-934E1018252E> .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/P1476>	<http://www.wikidata.org/entity/statement/Q63393796-53E5EED1-E72A-437D-943F-8E14D1363CF2> .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/direct/P17>	<http://www.wikidata.org/entity/Q865> .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/direct/P17>	<http://www.wikidata.org/entity/Q224> .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/direct/P17>	<http://www.wikidata.org/entity/Q27> .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/direct/P6153>	<http://www.wikidata.org/entity/Q17066381> .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/P6153>	<http://www.wikidata.org/entity/statement/Q63393796-50654A73-7C8D-4086-B737-E2FEE1E5163F> .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/P6153>	<http://www.wikidata.org/entity/statement/Q63393796-58775EFE-7C38-4167-96BD-B192FEA35A06> .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/P1132>	<http://www.wikidata.org/entity/statement/Q63393796-DAB403C6-B3B8-47DC-86B6-7E384AC725C5> .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/P6153>	<http://www.wikidata.org/entity/statement/Q63393796-56B811A8-04B1-4D2A-BF62-80A564417279> .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/direct/P17>	<http://www.wikidata.org/entity/Q28> .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/direct/P17>	<http://www.wikidata.org/entity/Q334> .
<http://www.wikidata.org/entity/Q63393796>	<http://www.w3.org/2000/01/rdf-schema#label>	"Avelumab and Talazoparib in Untreated Advanced Ovarian Cancer (JAVELIN OVARIAN PARP 100)"@en .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/direct/P3098>	"NCT03642132" .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/P17>	<http://www.wikidata.org/entity/statement/Q63393796-F1A6B9DD-7194-46E2-877E-E3D541DE4FFB> .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/P17>	<http://www.wikidata.org/entity/statement/Q63393796-EBEF2FA7-8176-487E-A243-7198E5CEEF57> .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/P6153>	<http://www.wikidata.org/entity/statement/Q63393796-AD26A65C-9DE2-4D05-9B24-1FD056F69D95> .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/direct/P582>	"2022-02-09T00:00:00Z"^^<http://www.w3.org/2001/XMLSchema#dateTime> .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/direct/P17>	<http://www.wikidata.org/entity/Q36> .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/P6153>	<http://www.wikidata.org/entity/statement/Q63393796-AA4E3E39-7C5A-42F2-BBCB-3F9B3023D44D> .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/direct/P6153>	<http://www.wikidata.org/entity/Q39997> .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/P580>	<http://www.wikidata.org/entity/statement/Q63393796-42466E0B-C23E-4402-824A-EBD521E658D4> .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/direct/P1132>	"720"^^<http://www.w3.org/2001/XMLSchema#decimal> .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/P17>	<http://www.wikidata.org/entity/statement/Q63393796-DA92D7E8-AFEB-41EB-B4B2-F884BA7D57D0> .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/direct/P6153>	<http://www.wikidata.org/entity/Q30270654> .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/P17>	<http://www.wikidata.org/entity/statement/Q63393796-D04B488C-9DA2-4EAF-B4AF-2CD2CBE8DBDA> .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/direct/P6153>	<http://www.wikidata.org/entity/Q39988> .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/P17>	<http://www.wikidata.org/entity/statement/Q63393796-C26F05C1-21F1-4480-9627-CFCEB501E385> .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/P17>	<http://www.wikidata.org/entity/statement/Q63393796-B510D0EB-D052-4E03-8AF0-2D56220E9AD7> .
<http://www.wikidata.org/entity/Q63393796>	<http://schema.org/description>	"clinical trial"@en .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/P17>	<http://www.wikidata.org/entity/statement/Q63393796-8AEE6B0B-852D-4BA0-8BEF-3E74F9E24466> .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/direct/P859>	<http://www.wikidata.org/entity/Q206921> .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/direct/P17>	<http://www.wikidata.org/entity/Q212> .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/P17>	<http://www.wikidata.org/entity/statement/Q63393796-7A4D2127-81FD-4FFD-84B2-31DEF9ECAF9D> .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/direct/P6099>	<http://www.wikidata.org/entity/Q42824827> .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/direct/P6153>	<http://www.wikidata.org/entity/Q46992910> .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/P17>	<http://www.wikidata.org/entity/statement/Q63393796-71566FEB-134E-455C-B6C1-14113083AE7E> .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/P582>	<http://www.wikidata.org/entity/statement/Q63393796-A3296B34-1D29-49E4-BC93-C5F73D3F1F9D> .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/direct/P17>	<http://www.wikidata.org/entity/Q30> .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/P17>	<http://www.wikidata.org/entity/statement/Q63393796-5A01AB17-E330-41C0-8308-3E45FB146218> .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/direct/P6153>	<http://www.wikidata.org/entity/Q6905066> .
<http://www.wikidata.org/entity/Q63393796>	<http://schema.org/description>	"\u043A\u043B\u0456\u043D\u0456\u0447\u043D\u0435 \u0432\u0438\u043F\u0440\u043E\u0431\u0443\u0432\u0430\u043D\u043D\u044F"@uk .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/P6153>	<http://www.wikidata.org/entity/statement/Q63393796-26250C73-2480-4FDE-BD05-A3D0F623837C> .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/direct/P8363>	<http://www.wikidata.org/entity/Q78089383> .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/P2899>	<http://www.wikidata.org/entity/statement/Q63393796-86877937-5363-4E05-903A-06955318963F> .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/direct/P17>	<http://www.wikidata.org/entity/Q408> .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/P8363>	<http://www.wikidata.org/entity/statement/Q63393796-D1556D2A-DE05-4B9D-879A-7DA1BDEE192D> .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/P6153>	<http://www.wikidata.org/entity/statement/Q63393796-1727FAD3-EE3B-4667-A181-DB0DA408A708> .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/P17>	<http://www.wikidata.org/entity/statement/Q63393796-568BE3AC-C7B0-46A1-A45B-0ABF23736419> .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/direct/P2899>	"18"^^<http://www.w3.org/2001/XMLSchema#decimal> .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/P6153>	<http://www.wikidata.org/entity/statement/Q63393796-4FD2A5D6-2297-4592-AFBF-1E368174D37F> .
<http://www.wikidata.org/entity/Q63393796>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://wikiba.se/ontology#Item> .
<http://www.wikidata.org/entity/Q63393796>	<http://schema.org/description>	"klinisch onderzoek"@nl .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/direct/P1476>	"A RANDOMIZED, OPEN-LABEL, MULTICENTER, PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF AVELUMAB IN COMBINATION WITH CHEMOTHERAPY FOLLOWED BY MAINTENANCE THERAPY OF AVELUMAB IN COMBINATION WITH THE POLY (ADENOSINE DIPHOSPHATE [ADP]-RIBOSE) POLYMERASE (PARP) INHIBITOR TALAZOPARIB IN PATIENTS WITH PREVIOUSLY UNTREATED ADVANCED OVARIAN CANCER (JAVELIN OVARIAN PARP100)"@en .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/direct/P6153>	<http://www.wikidata.org/entity/Q4803501> .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/direct/P4844>	<http://www.wikidata.org/entity/Q25100990> .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/P4844>	<http://www.wikidata.org/entity/statement/Q63393796-CE9C2B3E-3344-427A-8000-F040F7747D2E> .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/P31>	<http://www.wikidata.org/entity/statement/Q63393796-E0B1BF21-BB34-4C6F-86AE-5E7E2678AB06> .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/P17>	<http://www.wikidata.org/entity/statement/Q63393796-118B44C2-5943-4533-BCAE-16923394159F> .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/direct/P17>	<http://www.wikidata.org/entity/Q31> .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/direct/P31>	<http://www.wikidata.org/entity/Q30612> .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/P17>	<http://www.wikidata.org/entity/statement/Q63393796-0C0C13BD-5B0E-4A55-A4A7-F43928740C3B> .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/P17>	<http://www.wikidata.org/entity/statement/Q63393796-07DA546D-7110-42BF-AA7E-9105C29A4538> .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/direct/P17>	<http://www.wikidata.org/entity/Q214> .
<http://www.wikidata.org/entity/Q63393796>	<http://schema.org/name>	"Avelumab and Talazoparib in Untreated Advanced Ovarian Cancer (JAVELIN OVARIAN PARP 100)"@en .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/direct/P17>	<http://www.wikidata.org/entity/Q17> .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/direct/P4844>	<http://www.wikidata.org/entity/Q413299> .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/direct/P6153>	<http://www.wikidata.org/entity/Q812573> .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/direct/P6153>	<http://www.wikidata.org/entity/Q30270369> .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/direct/P580>	"2018-07-19T00:00:00Z"^^<http://www.w3.org/2001/XMLSchema#dateTime> .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/P6099>	<http://www.wikidata.org/entity/statement/Q63393796-52D3F8E4-F79D-4868-A5F5-17021884C894> .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/direct/P6153>	<http://www.wikidata.org/entity/Q624119> .
<http://www.wikidata.org/entity/Q63393796>	<http://www.wikidata.org/prop/P6153>	<http://www.wikidata.org/entity/statement/Q63393796-EA961C18-88CB-4AC0-8880-A8EE29FE1592> .